説明

Curcumin bioavailability challenges and formulation strategies are discussed in the context of ulcerative colitis therapy. Enhanced formulations may improve local colonic delivery and therapeutic outcomes.

Figure 16

Diagram

Source Paper

The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.

Nutrients (2020)

PMID: 32751776

DOI: 10.3390/nu12082296

Cite This Figure

![Figure 16: Curcumin bioavailability challenges and formulation strategies are discussed in the context of ulcerative colitis therapy. Enhanced formulations may improve local colonic delivery and therapeutic outcomes.]()

> Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." *Nutrients*, 2020. PMID: [32751776](https://pubmed.ncbi.nlm.nih.gov/32751776/)

<figure>
  <img src="" alt="Curcumin bioavailability challenges and formulation strategies are discussed in the context of ulcerative colitis therapy. Enhanced formulations may improve local colonic delivery and therapeutic outcomes." />
  <figcaption>Figure 16. Curcumin bioavailability challenges and formulation strategies are discussed in the context of ulcerative colitis therapy. Enhanced formulations may improve local colonic delivery and therapeutic outcomes.<br>  Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751776/">32751776</a></figcaption>
</figure>

説明

Figure 16

Source Paper

Cite This Figure

関連するエビデンス